Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2019 2020 2021 2022 2023 2024 2025
Months
January February March April May June July August September October November December
Previous Archive
18 April 2024 | Story Andre Damons | Photo Charl Devenish
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), received the first clinical PhD in nuclear medicine completed at the UFS at the April graduation ceremonies.

Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine, Faculty of Health Sciences, at the University of the Free State (UFS), graduated with the first clinical PhD in nuclear medicine completed at the UFS.

He graduated on Thursday (18 April 2024) at the university’s autumn graduation ceremonies when the Faculty of Health Sciences conferred degrees on its graduation class of 2024.

Dr Evbuomwan, the man behind his department using Lutetium 177 PSMA (Lu-177 PSMA) therapy and now Actinium 225 PSMA therapy to treatment metastatic castrate resistant prostate cancer (MCRPC) – an advanced stage prostate cancer, said his PhD is about using a special radiopharmaceutical called Technetium 99m ECDG to detect active disease in the joints of patients with rheumatoid arthritis (RA).

More opportunities for similar degrees

This research has won him the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa during last year’s SNMMI 2023 Annual Meeting in the US.

“I am very grateful, and at the same time, proud about this achievement (his PhD). This qualification will definitely give more opportunities for further similar degrees at the department. So yes, I feel very happy and fulfilled.

“Rheumatoid arthritis is a debilitating disease with associated morbidity that can lead to serious joint deformity and destruction. The need for an investigation with a very high diagnostic accuracy in detecting active disease is needed, especially in the detection of subclinical disease. Few prior studies in the literature had shown promising results with Tc 99m ECDG imaging in this regard. So, we decided to conduct a proper prospective study to test this hypothesis,” says Dr Evbuomwan.

This research, he explains, was also aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. This aspect of the study concluded that this particular radiopharmaceutical (Tc – 99m ECDG) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints) and is capable of offering prognostic information in patients with rheumatoid arthritis.

This was the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says.

Researching theranostics in the future

According to him, he had a smooth journey to completing his PhD – something he contributes to support from the fantastic team of three supervisors, the assistant who prepared the radiopharmaceutical, the rheumatology department, the radiographers and nurses at the Department of Nuclear Medicine, and most importantly, his wife and two daughters.

His passion for research, growth and the practice of nuclear medicine were his major motivators on this journey.

Dr Evbuomwan is currently looking at the possibility of starting research on theranostics. The only stumbling block for now, he says, is that the department still does not have a PET/CT camera, as this is very vital in today’s nuclear medicine practice. However, together with the Free State Department of Health, they are working hard to secure one.

“I now want to focus on nuclear medicine therapy and its promotion. This includes both imaging and treatment (theranostics) of certain cancers, most especially prostate cancer, neuroendocrine neoplasms, thyroid cancers and the neuroectodermal tumours. I also want to focus on being involved with the training of more registrars at the department of nuclear medicine and increasing the awareness of nuclear medicine amongst colleagues in the Free State,” says Dr Evbuomwan about his future plans. 

News Archive

UFS hosts consortium to discuss broadening subcontinent’s food base
2017-03-14

Description: Cactus Tags: Cactus

The Steering Committee of the Collaborative
Consortium for Broadening the Food Base comprises,
from the left: Prof Wijnand Swart (UFS),
Dr Sonja Venter (ARC) and Dr Eric Amonsou (DUT).
Photo: Andrè Grobler

There is huge pressure on the agricultural industry in southern Africa to avert growing food insecurity. One of the ways to address this is to broaden the food base on the subcontinent via crop production. Climate change, urbanisation, population growth, pests and diseases continually hamper efforts to alleviate food insecurity. Furthermore, our dependence on a few staple crops such as maize, wheat, potatoes, and sunflower, serve to exacerbate food insecurity.  

Broadening the food base  
To address broadening the food base in southern Africa, scientists from the University of the Free State (UFS), the Durban University of Technology (DUT) and the Agricultural Research Council (ARC) have formed a Collaborative Consortium for the development of underutilised crops by focusing on certain indigenous and exotic crops. The Consortium met at the UFS this week for two days (6, 7 March 2017) to present and discuss their research results. The Principal Investigator of the Consortium, Prof Wijnand Swart of the Department of Plant Sciences in the Faculty of Natural and Agricultural Sciences, said awareness had risen for the need to rescue and improve the use of orphan crops that were up to now, for the most part, left aside by research, technological development, and marketing systems.  

"Many indigenous southern African
plant grains, vegetables and tubers
have the potential to provide a variety
of diets and broaden the household
food base.”

Traditional crops Generally referred to as alternative, traditional or niche crops, five crops are being targeted by the Consortium, namely, two grain legumes, (Bambara groundnut and cowpea), amaranthus (leaf vegetable), cactus pear or prickly pear and amadumbe (a potato-like tuber). Swart said these five crops would play an important role in addressing the food and agricultural challenges of the future. “Many indigenous southern African plant grains, vegetables and tubers have the potential to provide a variety of diets and broaden the household food base.” The potential of the many so-called underutilised crops lies not only in their hardiness and nutritional value but in their versatility of utilisation. "It may be that they contain nutrients that can be explored to meet the demand for functional foods," said Swart.

Scientific institutions working together
The Collaborative Consortium between the three scientific institutions is conducting multi-disciplinary research to develop crop value chains for the five underutilised crops mentioned above. The UFS and ARC are mainly involved in looking at production technologies for managing crop environments and genetic technologies for crop improvement. The DUT is focusing on innovative products development and market development.  

 

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept